Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia. - Wikidata - wikimedia - TriplyDB

Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia.

Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia.

http://www.wikidata.org/entity/Q34309928

about

microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment Emergence of polyclonal FLT3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT3-ITD-positive acute myeloid leukemia.miRNAs as Biomarkers in Chronic Myelogenous Leukemia Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemia Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.Lyn facilitates glioblastoma cell survival under conditions of nutrient deprivation by promoting autophagy.Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes.Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2 MicroRNA-181c targets Bcl-2 and regulates mitochondrial morphology in myocardial cells.BIRC6 mediates imatinib resistance independently of Mcl-1.Specific Roles of MicroRNAs in Their Interactions with Environmental Factors.microRNAs: innovative targets for cerebral ischemia and stroke.Induction of K562 Cell Apoptosis by As4S4 via Down-Regulating miR181.The role of microRNAs in B-cell development and function.Chronic myeloid leukemia stem cells and developing therapies.Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.Epigenetic regulation of osteoclast differentiation.MicroRNA-181a - a tale of discrepancies.MicroRNAs in myeloid malignancies.Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes.Analogs, formulations and derivatives of imatinib: a patent review.MicroRNAs in Myeloid Hematological Malignancies.MicroRNAs and Gastrointestinal Stromal Tumor.MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.Garcinol downregulates Notch1 signaling via modulating miR-200c and suppresses oncogenic properties of PANC-1 cancer stem-like cells.miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model.New insights into vitamin D anticancer properties: focus on miRNA modulation.miRNAs in chronic myeloid leukemia: small molecules, essential function.MicroRNAs regulate B-cell receptor signaling-induced apoptosis.Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia.Understanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine.Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia.Post-Transcriptional Regulation of Anti-Apoptotic BCL2 Family Members.MicroRNA-181 inhibits proliferation and promotes apoptosis of chondrocytes in osteoarthritis by targeting PTEN.MicroRNAs and immunity in periodontal health and disease Biological Aspects of mTOR in Leukemia

P2860

Q26778918-75985AAF-EBAC-4215-8468-5394DBF4BB06 Q27852520-60E4FAF9-6285-4E01-B5B4-8A9792B4FD30 Q28087081-2D7E45AE-76A8-4EF3-ADDA-A4D377009741 Q28534259-58125F8B-7AD2-431B-B141-9433936FBE30 Q34173253-01218D54-DAB2-40DA-BAB6-CF181A56331A Q34926222-7A0766C4-98FC-4D92-9186-0E8118AD3626 Q35137424-928AE17D-D33A-4F61-9E0F-38525E512B83 Q35649100-18FBB54B-AEFE-4FA4-A356-66C6E6BD074B Q35679353-EB61B674-E3C1-4DDB-9A42-A8FA7C4B25C3 Q35832262-A3DC5630-0CEF-49FB-94F4-2EABE2344234 Q36057457-5FF83698-DB83-405B-AAE2-18F6AF3DE3A1 Q36375641-560D2DA7-9A84-4B0F-AE5B-363F6B0C11F5 Q36411230-CDA5CD06-99E6-4E4E-B5F4-8DF8B2FCEA4B Q36905867-C254A0A3-C192-4890-8980-23A086B36B42 Q37591850-472BC6EC-E85D-4529-A177-08C21F134ECB Q37729365-5C121A05-F0A0-4A13-83F4-305B6A1280A7 Q37836936-CC591E6C-BFBC-447C-9315-1490DB25F32F Q37865381-F9DD57DA-340D-43FC-ABE1-00BCA426D6B0 Q37968675-75B2F99E-6F8C-4F2B-B845-0FBC5D5BF05E Q37986129-CBEF155F-8489-4941-8F00-1AC92EB8DF6F Q38107272-1BF20914-05E1-483C-A31A-6DB21ECDD769 Q38500323-01B64404-FCE7-40A3-BB87-5966636825CE Q38587332-3B31C007-79F5-4AB4-B454-FD05B4D6F2E0 Q38599595-767C47BE-C1F9-4B53-B19F-673B5F9C9814 Q38667013-B7045C09-1E8E-4692-84AF-B88CAEE904A6 Q38815005-F604A254-D381-4FB9-8093-039C1CC70D51 Q38833027-B42315FE-05DE-47CD-8BE3-92A5EC3C9E8A Q38862227-7C78ED98-B696-4C6B-8D5A-30C0901FC580 Q38938169-4A01240D-1F0D-402D-9FCD-10E2545FF1B0 Q38979577-609E8CCF-59FA-48DE-A54C-4CF91F47343F Q39392048-568D091D-AD8D-4647-919F-BF20160AB5F4 Q41890535-C3B25FBA-98E0-4D29-90B0-C6089C977E1D Q42117299-D812817B-01E2-4C0E-93B2-A3457CE582E8 Q47117016-3AE6AEDA-BA09-4EE4-9565-62A5A69138AF Q47716556-77301309-0D87-4F78-8CCE-AF3DCAA62705 Q50904628-526015D3-2C1B-459F-9297-FB5747DB03FD Q57170593-DCDEB200-9F48-4268-AF32-7424E9B73C09 Q58780065-CC7EE1D9-0DCB-4639-86FF-CF5B8A32F3E3

P2860

Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia.

http://www.wikidata.org/entity/Q34309928

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Lyn kinase-dependent regulatio ...... tance in myelogenous leukemia.

@ast

Lyn kinase-dependent regulatio ...... tance in myelogenous leukemia.

@en

Lyn kinase-dependent regulatio ...... tance in myelogenous leukemia.

@nl

type

label

Lyn kinase-dependent regulatio ...... tance in myelogenous leukemia.

@ast

Lyn kinase-dependent regulatio ...... tance in myelogenous leukemia.

@en

Lyn kinase-dependent regulatio ...... tance in myelogenous leukemia.

@nl

prefLabel

Lyn kinase-dependent regulatio ...... tance in myelogenous leukemia.

@ast

Lyn kinase-dependent regulatio ...... tance in myelogenous leukemia.

@en

Lyn kinase-dependent regulatio ...... tance in myelogenous leukemia.

@nl

P1433

Q34309928-74E39073-A461-44A6-A812-DF1580B81C30

P1476

Q34309928-C07219CD-8F1B-44F0-9339-0059C7CA3A32

P2093

Q34309928-0A2049CA-F443-4BEC-AB1F-AF968AB5164D

Q34309928-197D5354-DFA3-4257-9405-93AE3C675D52

Q34309928-21BD3856-02BB-48D1-9CE7-C38DFA1B7C91

Q34309928-78AE14EA-CB1F-4CEF-BDF3-0BF23ACB5F4E

Q34309928-8F0D0141-297A-4B58-A861-B87C467CF307

Q34309928-9BD9F852-E63D-4DA1-9C9A-4A1E7765F9D3

Q34309928-D9A4285E-5B52-4515-B7FE-5DDE30FE661C

Q34309928-F5131740-0147-4761-81A0-06A4CB497511

P2860

Q34309928-037E64AB-B084-45EA-B32D-E40CFEB299F9

Q34309928-0785F1EA-EF5E-4715-8414-49426D39EBED

Q34309928-15F19E78-090E-4DED-B471-4AD0A0D7CFF4

Q34309928-274FF973-8012-4DE9-81E4-33116FF7C316

Q34309928-2D4BAEAF-DA2B-4EF6-8B35-65F09E94F8B9

Q34309928-2D9A98BB-A1D6-417A-B04A-010E21705174

Q34309928-2E2D6E49-CEB8-40AB-B9F2-C9649766D33B

Q34309928-2E594993-5C40-4B48-9B08-2C04E168AC6E

Q34309928-3ABDA5CD-68E5-499E-9183-1756C9A597D0

Q34309928-3FD977B9-417D-490D-966D-30FE2E6483A0

P304

Q34309928-5BEC0B3D-AFC9-4D42-8507-E5BC946B52D1

P31

Q34309928-E645A89E-F8ED-4017-B90C-8F17776CA156

P356

Q34309928-D1B42923-86B2-4261-955A-39E2FDAB5793

P433

Q34309928-1C0D1F8F-30A7-43E7-A658-A2C3FB7098A9

P478

Q34309928-6A5B2DC5-65AD-4269-AAC7-02479F602018

P577

Q34309928-16B439EA-E4DC-4A72-BF01-8A1C57CFC263

P5875

Q34309928-A38E5D9A-4BA9-4601-922F-B949C7963F9D

P698

Q34309928-3E026442-673C-4436-83DB-4E982DAB8285

P921

Q34309928-C5164A71-CBE0-4EE4-AA0F-5DE87120E794

P932

Q34309928-370CE4B4-EAEA-4907-B381-0BC9B9B9ABEA

P356

P1433

Molecular Pharmacology

P1476

Lyn kinase-dependent regulatio ...... tance in myelogenous leukemia.

@en

P2093

Claudia M Dollins

http://www.w3.org/2001/XMLSchema#string

Eric I Zimmerman

http://www.w3.org/2001/XMLSchema#string

Kristy L Richards

http://www.w3.org/2001/XMLSchema#string

Lee M Graves

http://www.w3.org/2001/XMLSchema#string

Melissa Crawford

http://www.w3.org/2001/XMLSchema#string

Scott M Hammond

http://www.w3.org/2001/XMLSchema#string

Serge P Nana-Sinkam

http://www.w3.org/2001/XMLSchema#string

Steven Grant

http://www.w3.org/2001/XMLSchema#string

P2860

Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia

Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis

mir-29 regulates Mcl-1 protein expression and apoptosis

Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing

The two major imatinib resistance mutations E255K and T315I enhance the activity of BCR/ABL fusion kinase.

FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L).

MicroRNAs modulate hematopoietic lineage differentiation

microRNAs: tiny regulators with great potential

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

P304

811-817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/MOL.110.066258

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45537888

http://www.w3.org/2001/XMLSchema#string

P698

20693279

http://www.w3.org/2001/XMLSchema#string

P921

P932

2981365

http://www.w3.org/2001/XMLSchema#string